Summary
To assess the cause of the digoxin-amiodarone interaction, the systemic availability and renal excretion of digoxin were examined in 10 patients. Patients were studied before and after 1 week and 6 weeks of concurrent amiodarone therapy, and four were also studied after 4–8 months.
Mean (±SD) peak plasma digoxin concentration rose from 1.55±0.6 μg/l prior to amiodarone therapy to 2.85±1.3 μg/l after 1 week of combined therapy (p<0.01). Mean AUC also rose from 7.2±2.1 μg/l.h to 12.1±6.4 μg/l.h (p<0.01) during this period. Mean peak plasma digoxin concentration and AUC remained elevated after 6 weeks and, in the patients studied, at 4–8 months. Mean urinary digoxin clearance remained unchanged. Plasma amiodarone and desethylamiodarone concentrations were consistent with the prescribed doses.
This study confirmed previous findings of raised plasma digoxin concentrations following the addition of amiodarone. It has also shown that this interaction is sustained for at least several months. The cause has not been fully elucidated but does not appear to be due to a change in the renal clearance of digoxin.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Moysey JO, Jaggarao NSV, Grundy EN, Chamberlaind DA. Amiodarone increases plasma digoxin concentrations.Br Med J 1981; 282:272–273.
Berdeaux A, Valette H, Auzepy P, Blondeau M, Giudicelli JF. Influence de l'amiodarone sur la digoxinémie.Nouv Presse Med 1981; 10:3650.
Marcus FI. Drug interactions with amiodarone.Am Heart J 1983; 106:924–930.
Fenster PE, White NW, Hanson CD. Pharmacokinetic evaluation if the digoxin-amiodarone interaction.J Am Coll Cardiol 1985; 5:108–112.
Nademanee K, Kannan R, Hendrickson J, Ookhtens M, Kay I, Singh BN. Amiodarone-digoxin interaction: Clinical significance, time course of development, potential pharmacokinetic mechanisms and therapeutic implications.J Am Coll Cardiol 1984; 4:111–116.
Douste-Blazy PH, Montastruc JL, Bonnet B, Auriol P, Conte D, Bernadet P. Influence of amiodarone on plasma and urine digoxin concentrations (letter).Lancet 1984; 1:905.
Koren G, Hesslein PS, MacLeod SM. Digoxin toxicity associated with amiodarone therapy in children.J Pediatr 1984; 104:467–470.
Venkatesh N, Singh BN, Al-Sarraf L, Kannan R. Digoxin-desethylamiodarone interaction in the rat: Comparison with the effects of amiodarone.J Cardiovasc Pharmacol 1986; 8:309–313.
O'Brien MS, Huston JR, Reid RJ, Gibson TP. Pitfalls in, and new methods for, the radioimmunoassay for digoxin in urine.Clin Chem 1985; 31:122–124.
Storey GCA, Holt P, Curry PVL, Holt DW. High-performance liquid chromatographic measurement of amiodarone and its desethyl metabolite: Methodology and premliminary observations.Therap Drug Monit 1982; 4:385–388.
Ritschel WA.Handbook of Basic Pharmacokinetics, 3rd Edition. Drug Intelligence Publication Inc: Hamilton, IL 1986; 270.
Tucker GT. Measurement of renal clearance of drugs.Br J Clin Pharm 1981; 12:761–760.
Grahame-Smith DG, Aronson JK.Oxford Textbook of Clinical Pharmacology and Drug Therapy. Oxford: Oxford University Press, 1984; 21.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Robinson, K., Johnston, A., Walker, S. et al. The digoxin-amiodarone interaction. Cardiovasc Drug Ther 3, 25–28 (1989). https://doi.org/10.1007/BF01881526
Issue Date:
DOI: https://doi.org/10.1007/BF01881526